Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drug
Biotech's IPO summer isn't over yet. Electra Therapeutics plans to begin public trading on the Nasdaq after the Labor Day holiday, according to a Friday IPO filing with securities regulators. While ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.